{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":324,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-09-14T18:21:24.973502+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho","slug":"keeping-an-early-stage-cell-therapy-biotech-in-the-black-with-in8bio-s-william-ho","published_at":"2026-06-22T10:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/keeping-an-early-stage-cell-therapy-biotech-in-the-black-with-in8bio-s-william-ho","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/19360445-keeping-an-early-stage-cell-therapy-biotech-in-the-black-with-in8bio-s-william-ho.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/19360445-keeping-an-early-stage-cell-therapy-biotech-in-the-black-with-in8bio-s-william-ho.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Ho, CEO of IN8bio, explains why gamma delta T cells may have an edge against cancer, including solid tumors like glioblastoma. He also offers up a candid and step-by-step look at what it takes to finance an early clinical-stage cell therapy company through a punishing IPO market and a long cash crunch. Access this and hundreds of episodes of the Business of Biotech videocas...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Ho, CEO of IN8bio, explains why gamma de…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3313,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/keeping-an-early-stage-cell-therapy-biotech-in-the-black-with-in8bio-s-william-ho/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/keeping-an-early-stage-cell-therapy-biotech-in-the-black-with-in8bio-s-william-ho.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}